“Omalizumab: New Addition to Dermatologic Therapy for Chronic Spontaneous Idiopathic Urticaria”. Journal of Pakistan Association of Dermatologists, vol. 25, no. 4, Nov. 2016, pp. 249-51, https://doi.org/10.66344/jpad.v25i4.139.